Conclusion: Our study revealed that HMGB1 is positively related to the improved prognosis in NSCLC, and demonstrate that HMGB3 might be a risk factor for poorer survival of NSCLC patients. This evidence concerns the gene HMGB3 and non-small cell lung carcinoma.